Biopsy Processing Articles & Analysis

1 news found

Xilis Raises $70 Million Series A Financing to Advance Diagnostic and Drug Discovery and Development Platform Leveraging Proprietary MicroOrganoSphere Technology

” Xilis’ MOS has been proven to have broad applications: Leveraging MOS and AI-driven algorithms, Xilis is developing its Precision Oncology Platform to accurately predict therapeutic responses to help clinicians prioritize cancer treatment strategies for each patient. The entire process from patient biopsy to results takes less than two weeks, ...

Jul. 8, 2021

ByXILIS, Inc.

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you